Home
HelpTest ID BLOD1138 Histamine Release-Chronic Urticaria
Specimen Type/Requirements
Red top (Serum w/out gel) tube - Serum
Patients taking calcineurin inhibitors should stop taking their medication for 72 hours prior to draw.
Test is affected by hemolysis and lipemia.
Specimen Volume
| Preferred Volume | 1.5 mL |
|---|---|
| Minimum Volume | 1.0 mL |
Performed Test Frequency
Tuesday, Thursday
Report Available
4 - 9 days
Methodology
Cell Culture, Immunoassay
Performing Lab
Quest Chantilly forwards to Quest San Juan Capistrano
CPT
86343
Interface Build Information
| Result Code | Result Code Description |
|---|---|
| 8636 | Histamine Release (Chronic Urticaria) |
| 8766 | Result Received Histamine Release |
Stability/Transport
| Room Temperature | 7 days | |
|---|---|---|
| Refrigerated | 7 days | Preferred for transport |
| Frozen | 30 days |
Additional Information
Includes Histamine Release (Chronic Urticaria)
Coverage Limitations
This test has limited coverage - please submit Commercial Insurance Patient Waiver (Non-Medicare) if applicable.
AKA
Anti-IgE Receptor Chronic Urticaria
FCER1
FFC Epsilon Receptor Antibody
CU (Chronic Urticaria)